0.67 USD
↘ 0.02 (2.90%)AT CLOSE (11:59 AM EDT)
Mustang Bio, Inc.
MBIONASDAQ • USD
0.69
↗ 0.02 (2.99%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
0.69
↗ 0.02 (2.99%)
Market: CLOSED
Open?$0.69
High?$0.78
Low?$0.67
Prev. Close?$0.69
Volume?5.0M
Avg. Volume?217.2K
VWAP?$0.72
Rel. Volume?23.15x
Bid / Ask
Bid?$0.83 × 1.2K
Ask?$6.30 × 600
Spread?$5.47
Midpoint?$3.57
Valuation & Ratios
Market Cap?5.1M
Shares Out?6.7M
Float?6.2M
Float %?92.0%
P/E Ratio?N/A
P/B Ratio?0.59
EPS?-$0.36
Dividend?0.00%
Ex-Dividend?N/A
MBIO is currently priced at $0.67. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Themes
Employees
4
Market Cap
5.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2017-08-22
Address
95 SAWYER RD
WALTHAM, MA 02453
Phone: (781) 652-4500
WALTHAM, MA 02453
Phone: (781) 652-4500
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?85
Piotroski F-Score?0/9Weak
Altman Z-Score?-33.37Distress
Confidence?40%Low
Short InterestLow
Short % of Float?0.87%Low
Short Interest?53.6K
Days to Cover?1.3
Free Float6.2M
Avg Daily Volume40.8K
Settlement Date2026-05-15
Financial Health
Current Ratio?2.12Strong
Quick Ratio?2.12Strong
Cash Ratio?2.07Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.59CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?3.5CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-31.7%WEAK▾
S&P6
ROA?-16.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-11181072
Fundamentals ratios updated end of day